Carregant...
Kappa-opioid antagonists for psychiatric disorders: from bench to clinical trials
Kappa-opioid receptor (KOR) antagonists are currently being considered for the treatment of a variety of neuropsychiatric conditions, including depressive, anxiety, and substance abuse disorders. A general ability to mitigate the effects of stress, which can trigger or exacerbate these conditions, m...
Guardat en:
| Publicat a: | Depress Anxiety |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5288841/ https://ncbi.nlm.nih.gov/pubmed/27699938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/da.22500 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|